| Mount Olivet Careview Home | |
| 5517 Lyndale Avenue South, Minneapolis, Minnesota 55419 | |
| (612) 827-5677 | |
| Name | Mount Olivet Careview Home |
|---|---|
| Location | 5517 Lyndale Avenue South, Minneapolis, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 155 |
| Occupancy Rate | 90.97% |
| Medicare ID (CCN) | 245071 |
| Legal Business Name | Mount Olivet Careview Home |
| Ownership Type | Non Profit - Church Related |
| NPI Number | 1285633537 |
| Organization Name | MOUNT OLIVET CAREVIEW HOME |
| Address | 5517 Lyndale Ave S, Minneapolis, MN 55419 |
| Phone Number | 612-827-5677 |
News Archive
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
A large study analyzing 107,000 knee replacement surgeries found that African Americans were significantly more likely than white patients to be discharged to an inpatient rehabilitation or skilled nursing facility rather than home care after the procedure. Researchers also found that African American patients under 65 were more likely to be readmitted to the hospital within 90 days of a knee replacement.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
Middle school football players greatly reduce the chance of head injuries if they wear padded helmets and use safe tackling and blocking techniques, according to Rutgers researchers.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
A large study analyzing 107,000 knee replacement surgeries found that African Americans were significantly more likely than white patients to be discharged to an inpatient rehabilitation or skilled nursing facility rather than home care after the procedure. Researchers also found that African American patients under 65 were more likely to be readmitted to the hospital within 90 days of a knee replacement.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
Middle school football players greatly reduce the chance of head injuries if they wear padded helmets and use safe tackling and blocking techniques, according to Rutgers researchers.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.07 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.76 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 65.22 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.18 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.79 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.48 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.58 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.01 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.35 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.7 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 13.2 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.84 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.86 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.73 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 74.02 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.84 | 82.93 |
News Archive
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
A large study analyzing 107,000 knee replacement surgeries found that African Americans were significantly more likely than white patients to be discharged to an inpatient rehabilitation or skilled nursing facility rather than home care after the procedure. Researchers also found that African American patients under 65 were more likely to be readmitted to the hospital within 90 days of a knee replacement.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
Middle school football players greatly reduce the chance of head injuries if they wear padded helmets and use safe tackling and blocking techniques, according to Rutgers researchers.
› Verified 1 days ago
Walker Methodist Health Center Location: 3737 Bryant Avenue South, Minneapolis, Minnesota 55409 Phone: (612) 827-5931 | |
Mount Olivet Careview Home Location: 5517 Lyndale Avenue South, Minneapolis, Minnesota 55419 Phone: (612) 827-5677 | |
Fairview University Trans Serv Location: 2450 Riverside Avenue South, Minneapolis, Minnesota 55454 Phone: (612) 273-4197 | |
The Villa At Bryn Mawr Location: 275 Penn Avenue North, Minneapolis, Minnesota 55405 Phone: (612) 377-4723 | |
The Estates At Chateau Llc Location: 2106 Second Avenue South, Minneapolis, Minnesota 55404 Phone: (612) 874-1603 | |
Benedictine Health Center Of Minneapolis Location: 618 East 17th Street, Minneapolis, Minnesota 55404 Phone: (612) 879-2800 |